Cargando…
Evidence-based assessment of potential use of fingolimod in treatment of relapsing multiple sclerosis
Multiple sclerosis is an autoimmune inflammatory demyelinating disease of the central nervous system and represents one of the most common causes of chronic neurologic disability in young adults. All the current disease-modifying drugs are administered parenterally, and can be associated with varyin...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065557/ https://www.ncbi.nlm.nih.gov/pubmed/21468239 http://dx.doi.org/10.2147/CE.S10101 |